The Immune Biology of Microsatellite-Unstable Cancer

Area of Science:

• Oncology
• Immunology
• Genetics

Background:

• Deficient DNA mismatch repair (MMR) leads to frameshift mutations in coding microsatellites (cMS).
• These mutations generate neoantigens, making microsatellite-unstable (MSI) cancers highly immunogenic.
• MSI cancers share common neoantigens derived from driver mutations, eliciting immune responses in patients and Lynch syndrome individuals.

Purpose of the Study:

• To review the immune biology of MSI cancers.
• To outline novel concepts and research directions for MSI cancer therapeutics and vaccines.

Main Methods:

• Literature review of studies on DNA mismatch repair, microsatellite instability, neoantigens, and cancer immunology.
• Analysis of MSI cancer genome landscapes and associated immune responses.

Main Results:

• MSI cancers are characterized by a high mutational burden and the expression of specific neoantigens.
• Immune responses against these neoantigens are observed in individuals with MSI cancers and Lynch syndrome.
• Shared neoantigens present opportunities for targeted therapies and vaccines.

Conclusions:

• Understanding MSI cancer immune biology is crucial for developing effective treatments.
• Targeting shared neoantigens offers a promising strategy for therapeutic interventions and preventive vaccines.
• Future research should focus on leveraging MSI cancer genome landscapes for novel immunotherapies.